The role of CA 72-4, a new tumor marker in gastric cancer;Mide kanserinde yeni bir tümör markeri olan CA 72-4'ün yeri

Turkiye Klinikleri Journal of Medical Sciences

Volumn 26, Issue 1, 2006, Pages 3-8

  Göral, Vedat ^a   Yeşilbaǧdan, Haluk ^a   Kaplan, Abdurahman ^a   Şit, Dede ^a   Çelik, Murat ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gastric cancer; Tumor markers

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HUMAN; LIVER METASTASIS; MALE; STOMACH CANCER;

EID: 33144458480     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chan AO, Wong BC, Lam SK. Gastric cancer: Past, present and future. Can J Gastroenterol 2001;15:469-74.
2. Asghar RJ, Parsonnet J. Helicobacter pylori and risk for gastric adenocarcinoma. Semin Gastrointest Dis 2001; 12:203-8.
3. Akdoǧan RA, Arslan M, Özden A, Şanin B, Yilmaz U, Soykan İ. Mide tümörleri. Gastroenteroloji. 1. Baski. Ankara: Türk Gastroenteroloji Vakfi Yayini; 2002. p.107-12.
4. McCulloch P. Gastric cancer. Postgrad Med J 1996;72:450-7.
5. Steplewski Z, Chang TH, Herlyn M, Koprowski H. Release of monoclonal antibody-defined antigens by human carcinoma and melanoma cells. Cancer Res 1981;41:2723-7.
6. McIntire KR. Tumor markers; how useful are they? Hosp Pract (Off Ed) 1984;19:55-68.
7. Reiter W, Stieber P, Reuter C, et al. Prognostic value of preoperative serum levels of CEA, CA 19-9, CA 72-4 in gastric carcinoma. Anticancer Res 1997;17:2903-6.
8. Pacelli F, Doglietto GB, Alfieri S, et al. Survival in early gastric cancer: Multivariate analysis on 72 consecutive cases. Hepatogastroenterology 1999;46:1223-8.
9. Marrelli D, Roviello F, De Stefano A, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999;57:55-62.
10. Joypaul B, Browning M, Newman E, Byrne D, Cuschieri A. Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995;169:595-9.
11. Staab HJ, Anderer FA, Brummendorf T, Hornung A, Fischer R. Prognostic value of preoperative serum CEA levels compared to clinical staging: II. Stomach cancer. Br J Cancer 1982;45:718-27.
12. Byrne DJ, Browning MC, Cuschieri A. CA 72-4: A new tumour marker for gastric cancer. Br J Surg 1990;77:1010-3.
13. Ikeda Y, Oomori H, Koyanagi N, et al. Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer. Oncology 1995;52:483-6.
14. Ishigami S, Natsugoe S, Shuuichi H, et al. Clinical importance of preoperative carcinoembryonic antigen and Carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001;32:41-4.
15. Heptner G, Domschke S, Domschke W. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 1989;24:745-50.
16. Kodama I, Koufuji K, Kawabata S, et al. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA 19-9 and CEA. Int Surg 1995;80:45-8.
17. Ubukata H, Katano M, Mothashi G, et al. Evaluation of CA72-4 as a tumor marker in patients with gastric cancer. Gan To Kagaku Ryono 2003;30:1821-4.
18. Kaya H, Göral V, Yazanel O. Çeşitli malign hastaliklarda tümör göstergeleri. Turkiye Klinikleri J Gastroenterohepatol 1994;5:120-3.